Thursday, May 04, 2017 10:24:12 PM
Analysts expect ImmunoVaccine Inc. (TSX:IMV) to report $-0.02 EPS on May, 9.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.02 EPS. After having $-0.03 EPS previously, ImmunoVaccine Inc.’s analysts see -33.33% EPS growth. It is down 109.09% since September 27, 2016 and is uptrending. It has outperformed by 98.53% the S&P500.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM